| Cat. No. | Product Name | Information | 
            
                
            	| PC-49677 | PDS-0330 Claudin-1 inhibitor | PDS-0330 (PDS0330) is a first-generation, specific small molecule claudin-1 inhibitor with Kd of 22.9 uM in MST binding assays, impairs the interaction between claudin1 and pSrc/Src and alters survival signaling pathways. | 
            
                
            	| PC-49675 | DS07551382 PTDSS1 inhibitor | DS07551382 (DS 07551382) is potent, selective and orally active PTDSS1 (phosphatidylserine synthetase 1), suppresses phosphatidylserine (PS) production activity of PTDSS1 (IC50=100 nM) in cell-free assays, but not that of PTDSS2. | 
            
                
            	| PC-49648 | FK3453 TSLP inhibitor | FK3453 (FK 3453) is a novel inhibitor of thymic stromal lymphopoietin (TSLP) production, reduces both TSLP protein levels and mRNA levels both in vitro and in vivo. | 
            
                
            	| PC-49645 | TH8535 OGG1 inhibitor | TH8535 (TH-8535) is a potent, selective inhibitor of 8-oxo Guanine DNA Glycosylase 1 (OGG1) with IC50 of 0.2 uM. | 
            
                
            	| PC-49633 | BI-3231 HSD17B13 inhibitor | BI-3231 (BI 3231) is a potent, selective HSD17B13 (hydroxysteroid 17β-dehydrogenase 13) inhibitor with enzyme IC50 of 1 and 14 nM for human and mouse HSD17B13, respectively. | 
            
                
            	| PC-49632 | BI-0955 HSD17B13 inhibitor | BI-0955 is an inactive HSD17B13 control compound for BI-3231. | 
            
                
            	| PC-49630 | Levetiracetam SV2A ligand | Levetiracetam (UCB L059) an antiepileptic drug with a unique activity profile in animal models of seizure and epilepsy, binds to (pKi=5.2) and modulates synaptic vesicle protein SV2A. | 
            
                
            	| PC-49628 | PKR inhibitor C16 PKR inhibitor | PKR inhibitor C16 (GW506033X) is a specific small molecule inhibitor of double-stranded RNA-dependent protein kinase (PKR). | 
            
                
            	| PC-49621 | JYQ-88 PARK7 (DJ-1) inhibitor | JYQ-88 is a potent, selective and covalent PARK7 inhibitor with IC50 of 0.13 uM in DiFMUAc assays, 100-fold selectivity over UCHL1 (PARK5, IC50=11.1 uM), covalently modifies the active site Cys106. | 
            
                
            	| PC-49607 | NCP26 ProRS inhibitor | NCP26 is a potent, ATP-competitive prolyl-tRNA synthetase (ProRS, PRS) inhibitor, inhibits recombinant human ProRS in the presence of 100 μM proline with KD of 0.35 nM in TR-FRET assays. | 
            
                
            	| PC-49591 | DDIT Hyaluronan synthase inhibitor | DDIT is a potent, non-toxic inhibitor of hyaluronan synthesis via targeting hyaluronan synthase (HAS), significantly suppresses the aggressiveness of triple-negative breast cancer cells grown in tissue culture. | 
            
                
            	| PC-49589 | ARUK2001607 PI5P4Kγ inhibitor | ARUK2001607 is a potent, selective and brain penetrant PI5P4Kγ inhibitor with binding KD of 7.1 nM, pIC50 of 7.1 (PI5P4Kγ+). |